Feb 27, 2020 8:30 am EDT Key Opinion Leader Symposium on Role of Survivin in Cancer Biology and Potential of DPX-Survivac
Feb 25, 2020 8:00 am EDT Conference Call & Webcast To Report Updated Results Of Phase 2 DeCidE1 Study
Dec 9, 2019 8:00 am EDT Clinical update on Investigator-initiated SPiReLPhase 2 with Merck’s Keytruda® in relapse/refractory Diffuse Large B-cell Lymphoma (r/r DLBCL)